
European Medicines Agency Proposes New Data Sovereignty Rules
Elena Drumm · 8 min
A predictable regulatory environment and a wealthy patient base are making Swiss providers a target for transatlantic capital.

Switzerland's health system has long been considered too fragmented to consolidate.
At least four US-based sponsors have opened Zurich offices in the past year.
Every Monday morning, the definitive analysis of healthcare markets in your inbox.